LENVIMA, known generically as lenvatinib, is a prescription medication primarily used in the treatment of certain types of cancer. It is a type of targeted therapy known as a tyrosine kinase inhibitor (TKI), which works by blocking specific enzymes (tyrosine kinases) that promote cell growth. By inhibiting these enzymes, LENVIMA can help slow down or stop the growth of cancer cells. It is commonly prescribed for the treatment of thyroid cancer, renal cell carcinoma (kidney cancer), and hepatocellular carcinoma (liver cancer) among others. LENVIMA's effectiveness and usage may vary based on the specific type of cancer and its stage. Like all cancer medications, it can cause a range of side effects, and its use is carefully monitored by healthcare professionals.